Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

White Papers

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19 The World Health Organiz

Optimize your ADME/hAME study to overcome barriers and avoid delays for drug development success

The Optimize your ADMA/hAME study to overcome barriers and avoid delays for drug development success Optimization of human absorption, metabolism, and excretion (hAME) stu